F. Martinon, S. Krishnan, G. Lenzen et R. Magné, « Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA », European Journal of Immunology, vol. 23, no 7, , p. 1719–1722 (ISSN0014-2980, PMID8325342, DOI10.1002/eji.1830230749, lire en ligne, consulté le )
J. Probst, B. Weide, B. Scheel et B. J. Pichler, « Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent », Gene Therapy, vol. 14, no 15, , p. 1175–1180 (ISSN0969-7128, PMID17476302, DOI10.1038/sj.gt.3302964, lire en ligne, consulté le )
Benjamin Weide, Jean-Philippe Carralot, Anne Reese et Birgit Scheel, « Results of the first phase I/II clinical vaccination trial with direct injection of mRNA », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 31, no 2, , p. 180–188 (ISSN1524-9557, PMID18481387, DOI10.1097/CJI.0b013e31815ce501, lire en ligne, consulté le )
Benjamin Weide, Steve Pascolo, Birgit Scheel et Evelyna Derhovanessian, « Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 32, no 5, , p. 498–507 (ISSN1537-4513, PMID19609242, DOI10.1097/CJI.0b013e3181a00068, lire en ligne, consulté le )
Susanne M. Rittig, Maik Haentschel, Katrin J. Weimer et Annkristin Heine, « Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients », Molecular Therapy: The Journal of the American Society of Gene Therapy, vol. 19, no 5, , p. 990–999 (ISSN1525-0024, PMID21189474, PMCID3098631, DOI10.1038/mt.2010.289, lire en ligne, consulté le )
(en) Steve Pascolo, « Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies », European Journal of Pharmacology, vol. 771, , p. 139–144 (ISSN0014-2999, DOI10.1016/j.ejphar.2015.12.017, lire en ligne, consulté le )
(en) Cuiling Zhang, Giulietta Maruggi, Hu Shan et Junwei Li, « Advances in mRNA Vaccines for Infectious Diseases », Frontiers in Immunology, vol. 10, (ISSN1664-3224, DOI10.3389/fimmu.2019.00594, lire en ligne, consulté le )
(en) Margit Schnee, Annette B. Vogel, Daniel Voss et Benjamin Petsch, « An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs », PLOS Neglected Tropical Diseases, vol. 10, no 6, , e0004746 (ISSN1935-2735, PMID27336830, PMCIDPMC4918980, DOI10.1371/journal.pntd.0004746, lire en ligne, consulté le )
(en) Cuiling Zhang, Giulietta Maruggi, Hu Shan et Junwei Li, « Advances in mRNA Vaccines for Infectious Diseases », Frontiers in Immunology, vol. 10, (ISSN1664-3224, DOI10.3389/fimmu.2019.00594, lire en ligne, consulté le )
F. Martinon, S. Krishnan, G. Lenzen et R. Magné, « Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA », European Journal of Immunology, vol. 23, no 7, , p. 1719–1722 (ISSN0014-2980, PMID8325342, DOI10.1002/eji.1830230749, lire en ligne, consulté le )
J. Probst, B. Weide, B. Scheel et B. J. Pichler, « Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent », Gene Therapy, vol. 14, no 15, , p. 1175–1180 (ISSN0969-7128, PMID17476302, DOI10.1038/sj.gt.3302964, lire en ligne, consulté le )
Benjamin Weide, Jean-Philippe Carralot, Anne Reese et Birgit Scheel, « Results of the first phase I/II clinical vaccination trial with direct injection of mRNA », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 31, no 2, , p. 180–188 (ISSN1524-9557, PMID18481387, DOI10.1097/CJI.0b013e31815ce501, lire en ligne, consulté le )
Benjamin Weide, Steve Pascolo, Birgit Scheel et Evelyna Derhovanessian, « Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 32, no 5, , p. 498–507 (ISSN1537-4513, PMID19609242, DOI10.1097/CJI.0b013e3181a00068, lire en ligne, consulté le )
Susanne M. Rittig, Maik Haentschel, Katrin J. Weimer et Annkristin Heine, « Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients », Molecular Therapy: The Journal of the American Society of Gene Therapy, vol. 19, no 5, , p. 990–999 (ISSN1525-0024, PMID21189474, PMCID3098631, DOI10.1038/mt.2010.289, lire en ligne, consulté le )
(en) Steve Pascolo, « Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies », European Journal of Pharmacology, vol. 771, , p. 139–144 (ISSN0014-2999, DOI10.1016/j.ejphar.2015.12.017, lire en ligne, consulté le )
(en) Cuiling Zhang, Giulietta Maruggi, Hu Shan et Junwei Li, « Advances in mRNA Vaccines for Infectious Diseases », Frontiers in Immunology, vol. 10, (ISSN1664-3224, DOI10.3389/fimmu.2019.00594, lire en ligne, consulté le )
(en) Margit Schnee, Annette B. Vogel, Daniel Voss et Benjamin Petsch, « An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs », PLOS Neglected Tropical Diseases, vol. 10, no 6, , e0004746 (ISSN1935-2735, PMID27336830, PMCIDPMC4918980, DOI10.1371/journal.pntd.0004746, lire en ligne, consulté le )
F. Martinon, S. Krishnan, G. Lenzen et R. Magné, « Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA », European Journal of Immunology, vol. 23, no 7, , p. 1719–1722 (ISSN0014-2980, PMID8325342, DOI10.1002/eji.1830230749, lire en ligne, consulté le )
J. Probst, B. Weide, B. Scheel et B. J. Pichler, « Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent », Gene Therapy, vol. 14, no 15, , p. 1175–1180 (ISSN0969-7128, PMID17476302, DOI10.1038/sj.gt.3302964, lire en ligne, consulté le )
Benjamin Weide, Jean-Philippe Carralot, Anne Reese et Birgit Scheel, « Results of the first phase I/II clinical vaccination trial with direct injection of mRNA », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 31, no 2, , p. 180–188 (ISSN1524-9557, PMID18481387, DOI10.1097/CJI.0b013e31815ce501, lire en ligne, consulté le )
Benjamin Weide, Steve Pascolo, Birgit Scheel et Evelyna Derhovanessian, « Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 32, no 5, , p. 498–507 (ISSN1537-4513, PMID19609242, DOI10.1097/CJI.0b013e3181a00068, lire en ligne, consulté le )
Susanne M. Rittig, Maik Haentschel, Katrin J. Weimer et Annkristin Heine, « Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients », Molecular Therapy: The Journal of the American Society of Gene Therapy, vol. 19, no 5, , p. 990–999 (ISSN1525-0024, PMID21189474, PMCID3098631, DOI10.1038/mt.2010.289, lire en ligne, consulté le )
(en) Margit Schnee, Annette B. Vogel, Daniel Voss et Benjamin Petsch, « An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs », PLOS Neglected Tropical Diseases, vol. 10, no 6, , e0004746 (ISSN1935-2735, PMID27336830, PMCIDPMC4918980, DOI10.1371/journal.pntd.0004746, lire en ligne, consulté le )
F. Martinon, S. Krishnan, G. Lenzen et R. Magné, « Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA », European Journal of Immunology, vol. 23, no 7, , p. 1719–1722 (ISSN0014-2980, PMID8325342, DOI10.1002/eji.1830230749, lire en ligne, consulté le )
J. Probst, B. Weide, B. Scheel et B. J. Pichler, « Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent », Gene Therapy, vol. 14, no 15, , p. 1175–1180 (ISSN0969-7128, PMID17476302, DOI10.1038/sj.gt.3302964, lire en ligne, consulté le )
Benjamin Weide, Jean-Philippe Carralot, Anne Reese et Birgit Scheel, « Results of the first phase I/II clinical vaccination trial with direct injection of mRNA », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 31, no 2, , p. 180–188 (ISSN1524-9557, PMID18481387, DOI10.1097/CJI.0b013e31815ce501, lire en ligne, consulté le )
Benjamin Weide, Steve Pascolo, Birgit Scheel et Evelyna Derhovanessian, « Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients », Journal of Immunotherapy (Hagerstown, Md.: 1997), vol. 32, no 5, , p. 498–507 (ISSN1537-4513, PMID19609242, DOI10.1097/CJI.0b013e3181a00068, lire en ligne, consulté le )
Susanne M. Rittig, Maik Haentschel, Katrin J. Weimer et Annkristin Heine, « Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients », Molecular Therapy: The Journal of the American Society of Gene Therapy, vol. 19, no 5, , p. 990–999 (ISSN1525-0024, PMID21189474, PMCID3098631, DOI10.1038/mt.2010.289, lire en ligne, consulté le )
(en) Margit Schnee, Annette B. Vogel, Daniel Voss et Benjamin Petsch, « An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs », PLOS Neglected Tropical Diseases, vol. 10, no 6, , e0004746 (ISSN1935-2735, PMID27336830, PMCIDPMC4918980, DOI10.1371/journal.pntd.0004746, lire en ligne, consulté le )
(en) Steve Pascolo, « Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies », European Journal of Pharmacology, vol. 771, , p. 139–144 (ISSN0014-2999, DOI10.1016/j.ejphar.2015.12.017, lire en ligne, consulté le )
STEVE PASCOLO, Création d'un modèle murin associant l'inaction des gènes h-2 de classe i et l'expression d'une molecule hla de classe i monocaténaire pour l'étude des réponses cytotoxiques restreintes par hla-a*0201, Paris 6, (lire en ligne)